title: Silencing Ku80 using small interfering RNA enhanced radiation sensitivity in vitro and in vivo.
abstract: Ku80 is an important component of DNA double-strand break repair, and Ku80 deficiency leads to extreme sensitivity to ionizing radiation. We studied whether radiation therapy combined with Ku80 silencing by small interfering RNA enhances radiation sensitivity in vitro and in vivo. Seven human cancer cell lines were transfected with Ku80 siRNA included in hemagglutinating virus of Japan envelope vector. H1299 cells were implanted into male BALB/C nu/nu nude mice treated with Ku80 siRNA and irradiation. The survival rate of cell lines transfected with Ku80 siRNA decreased by 10% to 26% with 2-Gy irradiation compared with untransfected cell lines. The gamma-H2AX phosphorylation-positive rates of Ku80 siRNA combined treatment 0.5 h after irradiation in A549 cells and 6 h in H1299 cells were significantly higher (77.6%, p=0.033 and 76.7%, p=0.026, respectively), compared with the groups not treated with siRNA. H1299 xenograft tumors treated with combined therapy decreased in volume and re-grew slowly compared with radiation alone. Our results indicate that combined therapy consisting of Ku80 siRNA and irradiation contributes to inhibition of tumor growth and may be a novel strategy for cancer treatment.
authors.affiliation: 21st Century Center of Excellence Program, Chiba University Graduate School of Medicine, Chiba 260-8677, Japan.
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Nimura
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Kawata
authors.forename: Katsuhiro
authors.initials: K
authors.lastname: Uzawa
authors.forename: Junko
authors.initials: J
authors.lastname: Okamura
authors.forename: Cuihua
authors.initials: C
authors.lastname: Liu
authors.forename: Masayoshi
authors.initials: M
authors.lastname: Saito
authors.forename: Hideaki
authors.initials: H
authors.lastname: Shimada
authors.forename: Naohiko
authors.initials: N
authors.lastname: Seki
authors.forename: Akira
authors.initials: A
authors.lastname: Nakagawara
authors.forename: Hisao
authors.initials: H
authors.lastname: Ito
authors.forename: Takenori
authors.initials: T
authors.lastname: Ochiai
authors.forename: Hideki
authors.initials: H
authors.lastname: Tanzawa
mesh_terms: D000818:Animals; D034961:Antigens, Nuclear / Q000235:genetics; D015153:Blotting, Western; D045744:Cell Line, Tumor; D053903:DNA Breaks, Double-Stranded / Q000528:radiation effects; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D005455:Fluorescent Antibody Technique; D020868:Gene Silencing; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D066298:In Vitro Techniques; D000072200:Ku Autoantigen; D008297:Male; D051379:Mice; D008819:Mice, Nude; D009374:Neoplasms, Experimental / Q000628:therapy*; D034741:RNA, Small Interfering; D011836:Radiation Tolerance / Q000502:physiology*; D014162:Transfection; D023041:Xenograft Model Antitumor Assays
chemical_list: D034961:Antigens, Nuclear; D004268:DNA-Binding Proteins; D034741:RNA, Small Interfering; C000606509:Xrcc6 protein, human; C000606510:Xrcc6 protein, mouse; D000072200:Ku Autoantigen